These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10615850)

  • 1. Moneychangers in the temple.
    Cole P; Delzell E; Rodu B
    Epidemiology; 2000 Jan; 11(1):84-90. PubMed ID: 10615850
    [No Abstract]   [Full Text] [Related]  

  • 2. Profile: Johns Hopkins Bloomberg School of Public Health at 100.
    Rubin R
    Lancet; 2016 Jun; 387(10036):2370. PubMed ID: 27312295
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of federal agency matching fund and cost-sharing policies on research universities and medical colleges.
    Feller I
    Acad Med; 1997 Dec; 72(12):1086-7. PubMed ID: 9435715
    [No Abstract]   [Full Text] [Related]  

  • 4. Moneychangers in the temple.
    Sommer A
    Epidemiology; 2000 Jul; 11(4):477-8. PubMed ID: 10874559
    [No Abstract]   [Full Text] [Related]  

  • 5. Universities should foster neglected-disease work.
    Chokshi DA
    Nature; 2005 May; 435(7039):143. PubMed ID: 15889064
    [No Abstract]   [Full Text] [Related]  

  • 6. Universities face cash shortfall as stock-market slide hits charities.
    Butler D
    Nature; 2002 Oct; 419(6909):765. PubMed ID: 12397312
    [No Abstract]   [Full Text] [Related]  

  • 7. US selects regional biodefence hubs.
    Dalton R
    Nature; 2003 Sep; 425(6954):110. PubMed ID: 12968137
    [No Abstract]   [Full Text] [Related]  

  • 8. Germany: Equality or excellence.
    Krieger A
    Nature; 2016 Sep; 537(7618):S12-3. PubMed ID: 27580134
    [No Abstract]   [Full Text] [Related]  

  • 9. Taking knowledge from bench to bank.
    Horton B; Wickware P; Gershon D; Gavaghan H
    Nature; 1998 Sep; 395(6700):409-14. PubMed ID: 9759734
    [No Abstract]   [Full Text] [Related]  

  • 10. Universities' value.
    Nature; 2015 Nov; 527(7577):133-4. PubMed ID: 26560261
    [No Abstract]   [Full Text] [Related]  

  • 11. UK universities face star treatment in funding revamp.
    Giles J
    Nature; 2003 Jun; 423(6940):574. PubMed ID: 12789301
    [No Abstract]   [Full Text] [Related]  

  • 12. Biobusiness on campus: commercialization of university-developed biomedical technologies.
    Dueker KS
    Food Drug Law J; 1997; 52(4):453-509. PubMed ID: 10346675
    [No Abstract]   [Full Text] [Related]  

  • 13. Seeds of collaboration.
    Smaglik P
    Nature; 2009 Oct; 461(7267):1158-9. PubMed ID: 19938370
    [No Abstract]   [Full Text] [Related]  

  • 14. Europe urged to provide boost for bioterror research.
    Abbott A
    Nature; 2002 Dec; 420(6915):450. PubMed ID: 12466800
    [No Abstract]   [Full Text] [Related]  

  • 15. From the Schools of Public Health. Realities for the accredited schools of public health.
    Spencer H
    Public Health Rep; 2002; 117(1):88-93. PubMed ID: 12297688
    [No Abstract]   [Full Text] [Related]  

  • 16. UK government lobbying for increased spending on universities intensifies.
    Birmingham K
    Nat Med; 1998 May; 4(5):539. PubMed ID: 9585210
    [No Abstract]   [Full Text] [Related]  

  • 17. Australia sets priorities for future research.
    Dennis C
    Nature; 2002 Dec; 420(6916):597. PubMed ID: 12478255
    [No Abstract]   [Full Text] [Related]  

  • 18. Universities fund off-the-wall research from their own pockets.
    Braben D
    Nature; 2018 Oct; 562(7726):192. PubMed ID: 30305750
    [No Abstract]   [Full Text] [Related]  

  • 19. Universities battle for extra funds in bid to boost quality.
    Schiermeier Q
    Nature; 2004 Feb; 427(6974):477. PubMed ID: 14765162
    [No Abstract]   [Full Text] [Related]  

  • 20. Recriminations inflame UK research debate.
    Adam D
    Nature; 2002 Jul; 418(6893):6. PubMed ID: 12097875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.